Until today, HER2-overexpression/gene amplification has been detected in multiple solid tumor entities including breast cancer, lung cancer, glioblastoma, head and neck cancer, pancreatic cancer, colorectal cancer, gastric cancer, or EAC [12]. The gene discussed is ERBB2; the disease is familial pancreatic carcinoma.